| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000027321 |
| Receipt No. | R000029014 |
| Scientific Title | Surgery for lower eyelid epiblepharon in children: a multi-center randomized controlled trial. |
| Date of disclosure of the study information | 2017/05/12 |
| Last modified on | 2020/07/30 (Ver. 7) |
| Basic information | ||
| Public title | Surgery for lower eyelid epiblepharon in children: a multi-center randomized controlled trial. | |
| Acronym | Surgery for lower eyelid epiblepharon in children: a multi-center RCT. | |
| Scientific Title | Surgery for lower eyelid epiblepharon in children: a multi-center randomized controlled trial. | |
| Scientific Title:Acronym | Surgery for lower eyelid epiblepharon in children: a multi-center RCT. | |
| Region |
|
|
| Condition | ||
| Condition | lower eyelid epiblepharon | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To compare the effectiveness and safety of the treatment result by the two types of surgical procedures between with performing a skin incision and without skin incision. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Cure rate (1 month and 6 months after surgical)
The severity of keratopathy and ciliary touch by slit-lump examination. |
| Key secondary outcomes | Recurrence rate, therapeutic effect, corneal shape, refraction, cosmetic, and safety.
The severity of keratopathy and ciliary touch by slit-lump examination, corneal topography, auto refract mater, optical coherence tomography and photography. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Suture method without skin incision | |
| Interventions/Control_2 | Modified Hotz procedure (with skin incision) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who are 3 to 15 years of age with the keratopathy due to epiblepharon, who want to undergo a surgical treatment.
When the ciliary touch is classified into three stages based on the previous report (Mild: contact with nasal conjunctiva, no corneal contact, Moderate: contact with nasal conjunctiva and cornea, Severe: contact with nasal conjunctiva, cornea and temporal conjunctiva), targeted to moderately relevant patients. |
|||
| Key exclusion criteria | 1. Patients with systemic syndrome.
2. Patients with facial anomalies / facial features abnormalities / eyelid tumors etc. that are thought to affect epiblepharon. 3. Patients who undergo surgery at the same time for upper epiblepharon or epicanthus. 4. Patients who have had a history of surgery on eyelids in the past. 5. Patients with abnormal lid closure, such as facial nerve paralysis, ptosis of the eyelids. 6. Traumatic epiblepharon. 7. Patients with keratoconjunctival disease not caused by epiblepharon. 8. Patients who can not respond to ophthalmologic examination mainly by slit lamp microscopy mainly due to the mental retardation. 9. Patients whose bleeding or scarring seems to be different from normal 10. Other patients who is unlikely to participate in the study, judge by the medical doctor. |
|||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Yokohama City University | ||||||
| Division name | Ophthalmology | ||||||
| Zip code | 2210825 | ||||||
| Address | 3 Chome-9 Fukuura, Kanazawa Ward, Yokohama, Kanagawa Prefecture | ||||||
| TEL | 09091488439 | ||||||
| ochan_tt@yahoo.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Yokohama City University | ||||||
| Division name | Ophthalmology | ||||||
| Zip code | 236-0004 | ||||||
| Address | 3 Chome-9 Fukuura, Kanazawa Ward, Yokohama, Kanagawa Prefecture | ||||||
| TEL | 045-787-2683 | ||||||
| Homepage URL | |||||||
| ochan_tt@yahoo.co.jp | |||||||
| Sponsor | |
| Institute | Yokohama City University
Department of Ophthalmology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Kanagawa Children's Medical Center |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Yokohama City University for Novel and Exploratory Clinical Trials |
| Address | 3 Chome-9 Fukuura, Kanazawa Ward, Yokohama, Kanagawa Prefecture |
| Tel | 045-787-2800 |
| nextjim1@yokohama-cu.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 50 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029014 |